Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Valentini

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Autoimmunity Reviews|October 11, 2003
The assessment of the patient with systemic sclerosisGabriele Valentini
Autoimmunity Reviews|December 3, 2014
Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc)Gabriele Valentini
Best Practice & Research. Clinical Rheumatology|December 11, 2002
Systemic sclerosisGabriele Valentini, Carol Black
Expert Opinion on Emerging Drugs|June 10, 2008
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosisGabriele Valentini, Marco Matucci Cerinic
Autoimmunity Reviews|September 17, 2020
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma?Gabriele Valentini, Janet E Pope
The Journal of Rheumatology|July 17, 2020
The Challenge of Very Early Systemic SclerosisAntonella Riccardi, Antonella Marcoccia, Gabriele Valentini
Rheumatology International|February 28, 2009
Early onset neutropenia after mycophenolate mofetil in systemic sclerosisGiovanna Cuomo, Giuseppina Abignano, Gabriele Valentini
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 4, 2018
The non-additive effects of body size on nest architecture in a polymorphic antChristina L Kwapich, Gabriele Valentini, Bert Hölldobler
Arthritis Research & Therapy|February 20, 2009
Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenarioIrene Miniati, Gabriele Valentini, Marco Matucci Cerinic
The Journal of Rheumatology|October 7, 2003
Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of diseaseGiovanni La Montagna, Salvatore D'Angelo, Gabriele Valentini
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Autoimmunity Reviews|October 11, 2003
The assessment of the patient with systemic sclerosisGabriele Valentini
Autoimmunity Reviews|December 3, 2014
Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc)Gabriele Valentini
Best Practice & Research. Clinical Rheumatology|December 11, 2002
Systemic sclerosisGabriele Valentini, Carol Black
Expert Opinion on Emerging Drugs|June 10, 2008
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosisGabriele Valentini, Marco Matucci Cerinic
Autoimmunity Reviews|September 17, 2020
Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma?Gabriele Valentini, Janet E Pope
The Journal of Rheumatology|July 17, 2020
The Challenge of Very Early Systemic SclerosisAntonella Riccardi, Antonella Marcoccia, Gabriele Valentini
Rheumatology International|February 28, 2009
Early onset neutropenia after mycophenolate mofetil in systemic sclerosisGiovanna Cuomo, Giuseppina Abignano, Gabriele Valentini
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 4, 2018
The non-additive effects of body size on nest architecture in a polymorphic antChristina L Kwapich, Gabriele Valentini, Bert Hölldobler
Arthritis Research & Therapy|February 20, 2009
Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenarioIrene Miniati, Gabriele Valentini, Marco Matucci Cerinic
The Journal of Rheumatology|October 7, 2003
Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of diseaseGiovanni La Montagna, Salvatore D'Angelo, Gabriele Valentini
Pageof 15